Celltrion Healthcare targets top end for $882m IPO

Celltrion Healthcare is on track to raise W1tr ($882.4m) as it eyes the top of guidance for its IPO, taking advantage of strong demand from international long-only funds, according to a source close to the deal.

  • By Jonathan Breen
  • 14 Jul 2017

The marketing affiliate of South Korean drug maker Celltrion was set to wrap up bookbuilding for its IPO at 5pm, Hong Kong time on Friday and price the deal shortly after.

The float comprised 24.6m primary shares, which the company was offering at W32,500-W41,000 apiece, giving it ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Panda Bonds Top Arrangers

Rank Arranger Share % by Volume
1 Bank of China (BOC) 28.15
2 CITIC Securities 21.52
3 China CITIC Bank Corp 9.93
4 China Merchants Bank Co 9.38
5 Industrial and Commercial Bank of China (ICBC) 7.73

Bookrunners of Asia-Pac (ex-Japan) ECM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 CITIC Securities 13,827.70 78 5.89%
2 UBS 13,692.33 82 5.83%
3 Goldman Sachs 10,720.86 54 4.57%
4 Morgan Stanley 10,186.93 54 4.34%
5 China Securities Co Ltd 9,861.82 46 4.20%

Bookrunners of Asia Pacific (ex-Japan) G3 DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 32,532.75 218 8.25%
2 Citi 30,515.32 184 7.74%
3 JPMorgan 23,972.21 138 6.08%
4 Bank of America Merrill Lynch 20,655.77 107 5.24%
5 Standard Chartered Bank 16,284.80 123 4.13%

Asian polls & awards